Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada

Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients DOWNERS GROVE, Ill., Feb. 24, 2026 /PRNewswire/ -- Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients +  Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE: INGR).

PRNewsWire • 7 hours ago

Ingredion's President and CEO Sells 33k Shares Before Becoming New Board Chairman

Ingredion's President and CEO sold 33,597 direct shares for a transaction value of approximately $4.02 million on Feb. 11, 2026. The sale represented 40.11% of Mr.

The Motley Fool • Feb 22, 2026

High Dividend Packaged Foods: Relative Favorability

The packaged foods industry has broadly declined over the last year with some producers dropping over 20%; dividend yields have expanded to as much as 9.5%. However, a high dividend yield does might not indicate value, profitability, or financial strength. Twenty-three high yield packaged food producers we compared on a matrix of factors including yield, payout ratio, value, growth, profitability, and debt.

Seeking Alpha • Feb 18, 2026

Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

Seeking Alpha • Feb 18, 2026

Ingredion Appoints President and CEO James P. Zallie as Chairman of the Board

WESTCHESTER, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, today announced that its board of directors has unanimously elected Jim Zallie, president and CEO, to assume the additional role of chairman of the board, effective immediately.

GlobeNewsWire • Feb 11, 2026

Ingredion: Defensive, High-Yield, Undervalued, And Transforming For Growth

Ingredion is reiterated as a Buy, supported by strong financial health and robust free cash flow exceeding guidance. INGR advances strategic pillars—protein and clean label ingredients—while completing its Cost2Compete program, achieving $59M in run-rate savings. 2026 guidance calls for low- to mid-single-digit net sales growth, EPS of $11–$11.80, and free cash flow midpoint of $460M.

Seeking Alpha • Feb 8, 2026

Ingredion Incorporated (INGR) Q4 2025 Earnings Call Transcript

Ingredion Incorporated (INGR) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 3, 2026

Ingredion Incorporated Reports 2025 Fourth Quarter and Full-Year Results

Reported and adjusted* EPS were $11.18 and $11.13 for full-year 2025, compared with $9.71 and $10.65 for full-year 2024 Cash from operations was $944 million for the full-year 2025, during which the Company returned $435 million to shareholders, including $224 million of share repurchases The Company expects its full-year 2026 outlook for reported and adjusted EPS to be in the range of $11.00 to $11.80 WESTCHESTER, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its fourth quarter 2025 and full-year 2025 results.

GlobeNewsWire • Feb 3, 2026

Ingredion (INGR) Misses Q4 Earnings and Revenue Estimates

Ingredion (INGR) came out with quarterly earnings of $2.53 per share, missing the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.63 per share a year ago.

Zacks Investment Research • Feb 3, 2026

Ingredion Q4: Poised For Lackluster First Half, But It Is Getting Interesting

Ingredion Incorporated delivered resilient profitability and has a strong balance sheet despite flat sales and US/Canada production setbacks. INGR guidance for 2024 is cautious: EPS of $11.00-$11.80, low-to-mid single-digit sales growth, and modest operating income improvement. Operational efficiency initiatives and R&D focus on Clean Labels and plant-based ingredients position INGR for future margin expansion.

Seeking Alpha • Feb 3, 2026